Madrigalв Dip «2K»
Investment firms, including and Piper Sandler , maintain a bullish outlook despite the price drop:
: Experts believe the U.S. market has approximately 1.5 million diagnosed MASH patients, providing "plenty of room" for multiple treatments, including Madrigal’s Rezdiffra. Clinical & Operational Status MadrigalВ Dip
: Following this news, Madrigal shares traded down roughly 5% . Investment Sentiment Investment firms, including and Piper Sandler , maintain
: Akero's results showed the potential for cirrhosis reversal, which temporarily overshadowed Madrigal's market position. including and Piper Sandler

